Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation.

Journal: Acta pharmaceutica Sinica. B •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Chen S, Wang X, Xuan Q, et al. (2026). "Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.08.007